Related Experiment Video
Updated: May 15, 2025

04:38
Subcostal Specimen Removal in Completely Portal Robotic Lobectomy
Published on: April 19, 2024
242
Comparison of Robot-Assisted Versus Video-Assisted Thoracoscopic Segmentectomy: A Single-Institution
Kojo Agyabeng-Dadzie1, Inderpal S Sarkaria1, Ernest Chan1
1University of Pittsburgh Medical Center, PA, USA.
Innovations (Philadelphia, Pa.)
|May 13, 2025
Summary
Robot-assisted thoracoscopic segmentectomy (RVATS) offers improved lymph node dissection and tumor margin compared to video-assisted thoracoscopic segmentectomy (VATS) for lung cancer, without compromising outcomes.
Area of Science:
- Thoracic Surgery
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Robot-assisted thoracoscopic segmentectomy (RVATS) and video-assisted thoracoscopic segmentectomy (VATS) are established techniques for lung cancer resection.
- Previous studies have explored the feasibility of RVATS versus VATS, but comprehensive outcome comparisons are limited.
Purpose of the Study:
- To compare short-term and long-term oncological and perioperative outcomes of RVATS and VATS for primary non-small cell lung cancer (NSCLC).
Main Methods:
- Retrospective propensity-matched cohort study of 108 RVATS and 370 VATS procedures for primary NSCLC (2013-2021).
- 1:2 propensity matching created matched cohorts of 102 RVATS and 204 VATS patients.
- Outcomes analyzed included mortality, readmission, morbidity, lymph node yield, operative time, margin status, and survival.
Main Results:
- No significant differences in 90-day mortality, 30-day readmission, or median lymph nodes harvested.
- RVATS demonstrated a greater median number of lymph node stations harvested and wider negative tumor margin distance.
- Postoperative morbidity was similar, except for a higher rate of pleural effusion in RVATS.
- All patients achieved R0 resection; 3-year disease-free and overall survival rates were comparable between groups.
Conclusions:
- RVATS facilitates harvesting more lymph node stations and achieving a greater negative tumor margin distance.
- These benefits of RVATS can be achieved without compromising short-term perioperative or long-term oncological outcomes in NSCLC segmentectomy.
- RVATS represents a valuable advancement for lung cancer segmentectomy, enhancing surgical precision and oncological clearance.

